HMG-CoA reductase inhibitors may affect thrombin generation by reducing factor VII activity in hyperlipidemic patients

被引：2
|
作者：
Ural, A. Ugur [1 ]
Avcu, Ferit
机构：
[1] Gulhane Mil Med Acad, Dept Hematol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Canc Res Ctr, Ankara, Turkey
[3] Gulhane Mil Med Acad, Dept Med & Canc Res Ctr, Ankara, Turkey
[4] Gulhane Mil Med Acad, Sch Med, Dept Hematol, TR-06010 Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2006年 / 118卷 / 05期
关键词：
D O I：
10.1016/j.thromres.2005.11.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：665 / 666
页数：2
相关论文
共 50 条
  • [1] Autoantibodies to oxidized LDL in hyperlipidemic patients treated with HMG-CoA reductase inhibitors
    Bui, MN
    Caulfield, MT
    Katz, P
    Cannon, RO
    Rackley, CE
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A296 - A296
  • [2] Do HMG-CoA reductase inhibitors affect fibrinogen?
    Song, JC
    White, CM
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 236 - 241
  • [3] Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
    Samizo, Shigeyoshi
    Kaneko, Hiromasa
    ACS OMEGA, 2023, 8 (30): : 27247 - 27255
  • [4] Pharmacophore model generation of HMG-CoA reductase inhibitors
    Bao Hong-Juan
    Zhang Yan-Ling
    Qiao Yan-Jiang
    ACTA PHYSICO-CHIMICA SINICA, 2008, 24 (02) : 301 - 306
  • [5] Are HMG-CoA reductase inhibitors underutilized in dialysis patients?
    Seliger, SL
    Stehman-Breen, CO
    SEMINARS IN DIALYSIS, 2003, 16 (03) : 179 - 185
  • [6] HMG-COA REDUCTASE KINASE - MEASUREMENT OF ACTIVITY BY METHODS THAT PRECLUDE INTERFERENCE BY INHIBITORS OF HMG-COA REDUCTASE-ACTIVITY OR BY MEVALONATE KINASE
    HARWOOD, HJ
    RODWELL, VW
    JOURNAL OF LIPID RESEARCH, 1982, 23 (05) : 754 - 761
  • [7] Risk of Diabetes in Patients Treated with HMG-CoA Reductase Inhibitors
    Wang, Hye Jin
    Cho, Yongin
    Choe, Eun Yeong
    Seo, Ji Won
    Lee, Yongho
    Yun, Yu Jung
    Kim, Gyuri
    Park, Sehee
    Bae, Jaehyun
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    DIABETES, 2014, 63 : A367 - A367
  • [8] Risk of diabetes in patients treated with HMG-CoA reductase inhibitors
    Cho, Yongin
    Choe, EunYeong
    Lee, Yong-ho
    Seo, Ji Won
    Choi, Younjeong
    Yun, Yujung
    Wang, Hye Jin
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (04): : 482 - 488
  • [9] EFFECTS OF HMG-COA REDUCTASE INHIBITORS IN HYPERCHOLESTEROLEMIC PATIENTS ON HEMODIALYSIS
    WANNER, C
    HORL, WH
    LULEY, CH
    WIELAND, H
    KIDNEY INTERNATIONAL, 1991, 39 (04) : 754 - 760
  • [10] HYPOLIPIDEMIC EFFECTS OF HMG-COA REDUCTASE INHIBITORS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    ILLINGWORTH, DR
    BACON, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (12): : G33 - G42
12345